IP Verse

Greiner, Elisabeth Analysis

LAW FIRM ANALYSIS

Latest European patent oppositions filed by Greiner, Elisabeth

Patent:
EP3626270
Title:
New Use
Applicant:
NOVARTIS AG
Opposition Date:
2024-07-11
Patent:
EP3294283
Title:
Sacubitril-Valsartan Dosage Regimen For Treating Heart Failure
Applicant:
NOVARTIS AG
Opposition Date:
2023-12-08
Patent:
EP3345607
Title:
Methods Of Altering Bone Growth By Administration Of Sost Or Wise Antagonist Or Agonist
Applicant:
OSSIFI-MAB LLC
Opposition Date:
2023-07-26
Patent:
EP2959894
Title:
S1P Receptor Modulators For Treating Multiple Sclerosis
Applicant:
NOVARTIS AG
Opposition Date:
2022-11-21
Patent:
EP2959894
Title:
S1P Receptor Modulators For Treating Multiple Sclerosis
Applicant:
NOVARTIS AG
Opposition Date:
2022-10-12
Patent:
EP3548000
Title:
Atropine Pharmaceutical Compositions
Applicant:
NEVAKAR, INC
Opposition Date:
2022-08-09
Patent:
EP3464373
Title:
Use Of Anti-Pd-1 Antibody In The Treatment Of Patients With Colorectal Cancer
Applicant:
BRISTOL-MYERS SQUIBB COMPANY
Opposition Date:
2022-07-27
Patent:
EP3426226
Title:
Ophthalmological Composition
Applicant:
URSAPHARM ARZNEIMITTEL GMBH
Opposition Date:
2022-06-09
Patent:
EP3288980
Title:
Treatment Of Pd-L1-Positive Melanoma Using An Anti-Pd-1 Antibody
Applicant:
BRISTOL-MYERS SQUIBB COMPANY
Opposition Date:
2021-12-10
Patent:
EP2968155
Title:
Tofacitinib Oral Sustained Release Dosage Forms
Applicant:
PFIZER INC.
Opposition Date:
2021-12-02

Top clients of Greiner, Elisabeth filing patent oppositions

Company:
GREINER, ELISABETH
Count:
6
Company:
ZENTIVA, K.S.
Count:
6
Company:
DF-MP DORRIES FRANK-MOLNIA & POHLMAN PATENTANWALTE RECHTSANWALTE PARG MBB
Count:
3
Company:
ZENTIVA K.S.
Count:
3
Company:
TEVA PHARMACEUTICAL INDUSTRIES LTD
Count:
2
Company:
PHARMA STULLN GMBH
Count:
2
Company:
SANDOZ AG
Count:
1
Company:
TEVA PHARMACEUTICAL INDUSTRIES LTD.
Count:
1
Company:
ZENTIVA GROUP, A.S.
Count:
1
Company:
HEXAL AG
Count:
1